Monday, December 23, 2024
HomeTagsTaletrectinib

Taletrectinib

Innovent Biologics and AnHeart Therapeutics Receive NMPA Breakthrough Designation for Taletrectinib in ROS1-Positive Non-Small Cell Lung Cancer

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics